Type I IFNs and their role in the development of autoimmune diseases

Author： Burdick Laura M Somani Najwa Somani Ally-Khan

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.8, Iss.4, 2009-07, pp. : 459-472

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Infections in the Pathogenesis of Autoimmune Diseases

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-02 ,pp. : 99-103

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Nitric Oxide in Autoimmune Diseases

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 3, Iss. 3, 2004-09 ,pp. : 223-238

Bentham Science Publishers

Access to resources Recommend Favorite

The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases

Drug Design Reviews - Online, Vol. 1, Iss. 1, 2004-01 ,pp. : 53-74

Bentham Science Publishers

Access to resources Recommend Favorite

The Impact of Fc Receptors on the Development of Autoimmune Diseases

Current Pharmaceutical Design, Vol. 9, Iss. 23, 2003-09 ,pp. : 1861-1870

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Defensins and Cathelicidin LL37 in Auto-Immune and Auto- Inflammatory Diseases

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. : 1882-1897

Bentham Science Publishers

Access to resources Recommend Favorite